World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
55112
World Ranking
3479
National Ranking
1914

Neil M. Bressler publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Neil M. Bressler sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 488 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Neil M. Bressler D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Neil M. Bressler sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 122 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Neil M. Bressler is affiliated with the Johns Hopkins University School of Medicine in the United States. Their academic work primarily focuses on the field of Medicine, with significant contributions to the subfields of Ophthalmology, Radiology, Nuclear Medicine and Imaging, General Health Professions, Public Health, Environmental and Occupational Health, and Health Informatics.

The main topics covered in their research include:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Retinal and Optic Conditions
  • Artificial Intelligence in Healthcare and Education
  • Healthcare cost, quality, practices
  • Glaucoma and retinal disorders
  • Ethics in Clinical Research

Neil M. Bressler has published extensively in multiple venues, with frequent publications in:

  • JAMA (32 publications)
  • JAMA Ophthalmology (22 publications)
  • American Journal of Ophthalmology (4 publications)
  • Translational Vision Science & Technology (3 publications)
  • Ophthalmology (3 publications)

Recent published papers include:

  • "Addressing Artificial Intelligence Bias in Retinal Diagnostics," 2021, Translational Vision Science & Technology
  • "Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration," 2020, JAMA Ophthalmology
  • "Low-Shot Deep Learning of Diabetic Retinopathy With Potential Applications to Address Artificial Intelligence Bias in Retinal Diagnostics and Rare Ophthalmic Diseases," 2020, JAMA Ophthalmology
  • "Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy," 2020, JAMA Ophthalmology
  • "Classification of Visual Field Abnormalities in Highly Myopic Eyes without Pathologic Change," 2022, Ophthalmology

Their frequent co-authors include:

  • Robert O. Bonow
  • Annette Flanagin
  • John Z. Ayanian
  • Dimitri Christakis
  • Preeti Malani

Best Publications

  • Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.

    Daniel Shu Wei Ting;Daniel Shu Wei Ting;Carol Yim Lui Cheung;Carol Yim Lui Cheung;Gilbert Lim;Gavin Siew Wei Tan;Gavin Siew Wei Tan

  • An international classification and grading system for age-related maculopathy and age-related macular degeneration

    A.C. Bird;N.M. Bressler;S.B. Bressler;I.H. Chisholm

  • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

    Neil M. Bressler

  • Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

    Michael J. Elman;Lloyd Paul Aiello;Roy W. Beck;Neil M. Bressler

  • Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.

    John A Wells;Adam R Glassman;Allison R Ayala

  • Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

    Neil M. Bressler

  • Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.

    John A. Wells;Adam R. Glassman;Allison R. Ayala;Lee M. Jampol

  • Age-related macular degeneration is the leading cause of blindness...

    Neil M. Bressler

  • The long-term effects of visible light on the eye

    Hugh R. Taylor;Sheila West;Beatriz Muñoz;Frank S. Rosenthal

  • A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

    Emmett T Cunningham;Anthony P Adamis;Michael Altaweel;Lloyd P Aiello

  • Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

    David J Browning;Adam R Glassman;Lloyd Paul Aiello

  • Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

    Michael J. Elman;Neil M. Bressler;Haijing Qin;Roy W. Beck

  • Automated Grading of Age-Related Macular Degeneration From Color Fundus Images Using Deep Convolutional Neural Networks

    Philippe M. Burlina;Neil Joshi;Michael Pekala;Katia D. Pacheco

  • The Age-Related Eye Disease Study (AREDS): Design Implications AREDS Report No. 1

    A. S. Lindblad;A. Kassoff;S. Kieval;M. Mehu

  • Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

    Jeffrey G. Gross;Adam R. Glassman;Lee M. Jampol;Seidu Inusah

  • A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.

    Ingrid U Scott;Allison R Edwards;Roy W Beck

  • Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

    Michael J. Elman;Allison Ayala;Neil M. Bressler;David Browning

  • Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1

    J. Arnold;D. Kilmartin;J. Olson;S. Neville

  • Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.

    Roy W Beck;Allison R Edwards;Lloyd P Aiello

  • Visual Function Abnormalities and Prognosis in Eyes with Age-related Geographic Atrophy of the Macula and Good Visual Acuity

    Janet S. Sunness;Gary S. Rubin;Carol A. Applegate;Neil M. Bressler

Frequent Co-Authors

Susan B. Bressler
Susan B. Bressler Johns Hopkins University School of Medicine
Lee M. Jampol
Lee M. Jampol Northwestern University
Frederick L. Ferris
Frederick L. Ferris National Institutes of Health
Roy W. Beck
Roy W. Beck University of South Florida
Philippe Burlina
Philippe Burlina Johns Hopkins University
Rohit Varma
Rohit Varma University of Southern California
Maureen G. Maguire
Maureen G. Maguire University of Pennsylvania
Lloyd Paul Aiello
Lloyd Paul Aiello Harvard University
Stuart L. Fine
Stuart L. Fine University of Colorado Denver
Stephan Heckers
Stephan Heckers Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine but are exploring alternative or complementary paths, a range of online healthcare degrees offer flexibility and accessibility. Some students find it easier to start with nursing programs with high acceptance rates, providing a valuable pathway into healthcare with less competitive entry requirements.

For those interested in administrative roles, pursuing a healthcare administration degree online accredited can open doors to leadership positions within hospitals, clinics, and medical offices. If direct patient care isn’t your primary interest, becoming a medical billing and coding specialist is another option. Many institutions with financial aid for medical billing and coding make this career path more affordable.

For current nursing professionals wishing to advance, there are lpn to rn programs without teas test requirements, streamlining the transition and reducing barriers to higher qualifications. Exploring these online degrees can help tailor your education to your strengths, ambitions, and lifestyle.

Best Scientists Citing Neil M. Bressler

Trending Scientists

Recently Published Articles